VRCA Next Earnings Date Notes

— Verrica Pharmaceuticals (NASDAQ: VRCA) is a dermatology-focused biopharmaceutical company innovating therapies for skin diseases, with a key emphasis on viral skin infections. Its lead product, YCANTH™, recently approved by the FDA in July 2023, is the first topical solution indicated for the treatment of molluscum contagiosum, a highly contagious skin disease with no FDA-approved treatments prior. Investors should closely monitor metrics such as YCANTH’s prescription uptake, revenue growth, gross-to-net discounts, and market penetration rate, as these numbers give insight into commercial execution & market acceptance. Additionally, R&D pipeline progress, particularly expanding YCANTH’s use to other indications like common warts, will be key for long-term value. Watch for updates on manufacturing capacity, sales force expansion, and cash runway, since these indicate the company's ability to scale and fund operations. Listening for management commentary on payer coverage & competitive landscape during the earnings call can also shed light on the durability and potential upside of Verrica's business, making these points essential for any VRCA investor tracking the company's trajectory. The next confirmed earnings date for VRCA is 5/12/2026 after close.

Verrica Pharmaceuticals Next Earnings Date FAQ

On this page we presented the Verrica Pharmaceuticals Next Earnings Date information for Verrica Pharmaceuticals along with recent past earnings dates. For Q4 of 2025, VRCA reported earnings of -0.510/share, with the earnings report taking place on 3/11/2026. For Q3 of 2025, VRCA reported earnings of 0.130/share, with the earnings report taking place on 11/14/2025. For Q2 of 2025, VRCA reported earnings of 0.250/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, VRCA reported earnings of -0.800/share, with the earnings report taking place on 5/13/2025. For Q4 of 2024, VRCA reported earnings of -1.800/share, with the earnings report taking place on 3/11/2025. And with these past earnings dates behind VRCA, investors can look ahead to the next confirmed earnings date of 5/12/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Verrica Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Verrica Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Verrica Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next VRCA earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up VRCA's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the VRCA next earnings date.